Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma
- PMID: 19785522
- DOI: 10.1089/thy.2008.0243
Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma
Abstract
Background: Recurrence of regional cervical lymph nodes in patients with papillary thyroid carcinoma (PTC) is not uncommon, and is an important factor affecting the quality of life. The aims of this study are to investigate the risk factors that are associated with regional lymph node recurrence by comparing a group of patients with regional lymph node recurrence with a group without lymph node recurrence, and to analyze the clinical characteristics of recurrent regional lymph nodes in PTC.
Methods: A retrospective analysis was performed on 189 patients who underwent surgery for PTC. By comparing a group with recurrent cervical lymph nodes (n = 33) with a group without recurrent cervical lymph nodes (n = 156), the risk factors for cervical lymph node recurrence were investigated and the clinical characteristics of recurrent cervical lymph nodes were analyzed.
Results: Tumor size >2 cm, presence of extrathyroid tumor spread, high T stage, and presence of lymph node metastasis were associated with regional lymph node recurrence in univariate analysis (p < 0.05). Among them, only the N stage was significantly associated with regional recurrence in multivariate analysis (p < 0.05). The disease-free survival period was shorter in the lymph node metastasis-positive group, and the 10-year disease-free survival rate was 77.8% in the lymph node metastasis-negative group and 57.9% in the lymph node metastasis-positive group (p < 0.05). Among 130 patients without lymph node metastasis, regional recurrence occurred in 13 patients (10%), and the frequent levels of regional recurrence were levels II-IV of ipsilateral neck. In the patients with lymph node metastasis, the frequent levels were levels IV-VI of ipsilateral side and level II of the contralateral side.
Conclusion: Considering the low incidence of regional lymph node recurrence and the levels with frequent regional recurrence in patients without lymph node metastasis, elective neck dissection in all cases of total thyroidectomy may be immoderate. However, if any risk factors for regional recurrence, including large tumor size, presence of extrathyroid spread, high T stage, and presence of lymph node metastasis, are detected by preoperative and intraoperative evaluation, a systematic compartment-oriented lymphadenectomy should be considered because of the high possibility of regional recurrence.
Similar articles
-
Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.Ann Surg Oncol. 2014 Nov;21(12):3872-5. doi: 10.1245/s10434-014-3896-y. Epub 2014 Sep 17. Ann Surg Oncol. 2014. PMID: 25227305
-
Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.Thyroid. 2009 Jul;19(7):707-16. doi: 10.1089/thy.2008.0270. Thyroid. 2009. PMID: 19348581
-
Papillary thyroid cancer: controversies in the management of neck metastasis.Laryngoscope. 2008 Dec;118(12):2161-5. doi: 10.1097/MLG.0b013e31818550f6. Laryngoscope. 2008. PMID: 19029855
-
[Lymph node dissection in non-medullary differentiated thyroid carcinoma].Ann Chir. 2006 Jul-Aug;131(6-7):361-8. doi: 10.1016/j.anchir.2005.10.009. Epub 2005 Nov 9. Ann Chir. 2006. PMID: 16329987 Review. French.
-
Peroperative diagnosis and treatment of metastases to the regional lymph nodes in papillary carcinoma of the thyroid gland.Surg Gynecol Obstet. 1989 Aug;169(2):107-14. Surg Gynecol Obstet. 1989. PMID: 2667172 Review.
Cited by
-
SHMT2 promotes papillary thyroid cancer metastasis through epigenetic activation of AKT signaling.Cell Death Dis. 2024 Jan 25;15(1):87. doi: 10.1038/s41419-024-06476-1. Cell Death Dis. 2024. PMID: 38272883 Free PMC article.
-
Metastatic papillary thyroid carcinoma in pleural effusion: a case report and review of the literature.J Med Case Rep. 2023 Dec 20;17(1):521. doi: 10.1186/s13256-023-04265-6. J Med Case Rep. 2023. PMID: 38115146 Free PMC article. Review.
-
A multicenter prospective study of lateral neck lymph node mapping in papillary thyroid cancer.Gland Surg. 2023 Nov 24;12(11):1500-1507. doi: 10.21037/gs-23-222. Epub 2023 Nov 17. Gland Surg. 2023. PMID: 38107486 Free PMC article.
-
Guiding the postoperative radioactive iodine-131 therapy for patients with papillary thyroid carcinoma according to the prognostic risk groups: a SEER-based study.J Cancer Res Clin Oncol. 2023 Dec;149(19):17147-17157. doi: 10.1007/s00432-023-05299-5. Epub 2023 Oct 2. J Cancer Res Clin Oncol. 2023. PMID: 37782329
-
Incidence and Clinicopathological Features of Differentiated High-Grade Thyroid Carcinomas: An Institutional Experience.Endocr Pathol. 2023 Sep;34(3):287-297. doi: 10.1007/s12022-023-09778-w. Epub 2023 Jul 29. Endocr Pathol. 2023. PMID: 37515661
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical